Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 184-198
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.184
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.184
Table 2 Results of multivariate analysis for survival factors in colon cancer patients
All patients (n = 144) | Patients with metastatic CC (n = 89) | |||
Adjusted HR (95%CI) | P value | Adjusted HR (95%CI) | P value | |
Low dmGFRA1 | 0.49 (0.24-0.98) | 0.044 | 0.41 (0.18-0.91) | 0.029 |
Age | 1.68 (0.83-3.40) | 0.147 | 1.69 (0.77-3.73) | 0.191 |
Sex | 1.45 (0.76-2.76) | 0.256 | 1.44 (0.71-2.91) | 0.317 |
Location | 2.60 (1.32-5.14) | 0.006 | 3.22 (1.48-7.01) | 0.003 |
Differentiation | 1.95 (0.65-5.89) | 0.235 | 2.02 (0.62-6.61) | 0.246 |
Vascular embolus | 0.32 (0.15-0.68) | 0.003 | 0.33 (0.15-0.74) | 0.007 |
Local invasion | 1.27 (0.71-2.28) | 0.421 | 1.16 (0.60-2.24) | 0.668 |
Metastasis | 4.92 (2.04-11.84) | 0.000 |
- Citation: Ma WR, Xu P, Liu ZJ, Zhou J, Gu LK, Zhang J, Deng DJ. Impact of GFRA1 gene reactivation by DNA demethylation on prognosis of patients with metastatic colon cancer. World J Gastroenterol 2020; 26(2): 184-198
- URL: https://www.wjgnet.com/1007-9327/full/v26/i2/184.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i2.184